CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

July 1st, 2010

Countdown to the FDA Panel: Avandia Resource Center

Source is CardioExchange News, unless otherwise noted.

FDA Releases Briefing Documents for Avandia Panel, 09 Jul 2010

More Evidence Goes Against Avandia, 28 Jun 2010

FDA Panels to Review Rosiglitazone and Dabigatran, 10 Jun 2010

CANOE Paddles Into the Avandia Storm, 03 Jun 2010

European Heart Journal Editors Defend Nissen Editorial, 03 May 2010

Industry Affiliation and Position on the Rosiglitazone Controversy, 20 Apr 2010, Journal Watch, Paul S. Mueller, MD, MPH, FACP

Will the FDA Halt Avandia Safety Study?, 19 Apr 2010

Rosiglitazone: When Evidence Is Inconclusive Even After FDA Approval, 03 Mar 2010, BLOG: The Expert Is In , Sanjay Kaul, MD

More Data on Fracture Risk with Thiazolidinediones, 02 Mar 2010, Journal Watch, Allan S. Brett, MD

Krumholz on Avandia,  25 Feb 2010

Avandia Roundup: AHA & ACC Publish Science Advisory on TZDs; GlaxoSmithKline White Paper, 24 Feb 2010

Avandia Remains in the News, 23 Feb 2010

Senators and FDA Officials Attack Avandia, 20 Feb 2010

Thiazolidinediones in Clinical Practice, 26 Aug 2009, Journal Watch, Harlan M. Krumholz, MD, SM

Categories: General


You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.